Long-term follow-up of psilocybin-facilitated smoking cessationAbstract Background: A recent open-label pilot study (N = 15) found that two to three moderate to high doses (20 and 30 mg/70 kg) of the...
Psilocybin produces substantial and sustained decreases in depression & anxiety in Cancer patientsCancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that...